Cipla 423 50 mg Pill - white capsule/oblong, 18mm
Pill with imprint Cipla 423 50 mg is White, Capsule/Oblong and has been identified as Celecoxib 50 mg. It is supplied by Cipla USA Inc.
Celecoxib is used in the treatment of Osteoarthritis; Ankylosing Spondylitis; Chronic Pain; Familial Adenomatous Polyposis; Juvenile Rheumatoid Arthritis and belongs to the drug class cox-2 inhibitors. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Celecoxib 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Cipla 423 50 mg
Celecoxib
- Imprint
- Cipla 423 50 mg
- Strength
- 50 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Cox-2 inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- National Drug Code (NDC)
- 69097-0423
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
povidone,
sodium lauryl sulfate,
gelatin
Note: Inactive ingredients may vary.
More about celecoxib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (275)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: cox-2 inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
